Back to AKTS

Merck & Co., Inc. → AKTS

Merck & Co., Inc. AKTS Position History

Aktis Oncology, Inc. • Healthcare

Quarters held
3
Latest value
$18.6M
Q3 2026
Peak value
$30.7M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$17M
Q2 2026$30.7M
Q3 2026$18.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$18.6M952.8K——
Q2 2026$30.7M952.8K——
Q1 2026$17M952.8K——

Other funds holding AKTS

Other Merck & Co., Inc. positions

MRNA

MODERNA INC

$444.5M
PR

PERSONALIS INC

$228.7M
PR

PERSONALIS INC

$188.2M
MRNA

MODERNA INC

$161.6M
MRNA

MODERNA INC

$117.3M
PR

PERSONALIS INC

$111.8M
PR

PERSONALIS INC

$89.5M
KYMR

KYMERA THERAPEUTICS INC

$88.5M